http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories
-
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
-
SCTbio and Fortrea form partnership for cell therapy development
-
SCTbio and Fortrea Forge Strategic Collaboration to Accelerate Cell and Gene Therapy Development and Delivery
-
Fortrea to Present at Upcoming Citi and Evercore Healthcare Conferences
-
Fortrea completes $75.7 million senior notes tender offer
-
Fortrea Completes $75.7 Million Senior Notes Tender Offer Utilizing Cash on Hand
-
Fortrea Appoints Agnieszka Gallagher as General Counsel
-
Fortrea Reports Third Quarter 2025 Results
-
Fortrea launches tender offer for up to $75.7 million of debt securities
-
Fortrea Announces Tender Offer for up to $75,744,000 Aggregate Purchase Price of Outstanding Debt
-
Fortrea adds William Sharbaugh to board of directors
-
Fortrea Appoints William Sharbaugh to Board of Directors
-
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
-
Fortrea Reports Second Quarter 2025 Results
-
Fortrea names Tracy Krumme as senior vice president of investor relations
-
Fortrea Appoints Tracy Krumme as Senior Vice President, Investor Relations
-
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
-
FTRE FINAL DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Fortrea Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 1 Deadline in Securities Class
-
FTRE FINAL DEADLINE: ROSEN, A LEADING NATIONAL FIRM, Encourages Fortrea Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 1 Deadline in Securities Class
-
FTRE DEADLINE NOTICE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Fortrea Holdings, Inc. Investors to Secure Counsel Before Important August 1 Deadline in Securities Class Action - FTRE
-
FTRE FINAL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Fortrea Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 1 Deadline in Securities Clas
-
FTRE DEADLINE: ROSEN, A HIGHLY REGARDED LAW FIRM, Encourages Fortrea Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - FT
-
Fortrea Announces Date for Second Quarter 2025 Financial Results and Conference Call
-
FTRE DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Fortrea Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - F
-
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Fortrea Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FTRE
-
ROSEN, A TOP RANKED LAW FIRM, Encourages Fortrea Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FTRE
-
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Fortrea Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FTRE
-
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Fortrea Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FTRE
-
ROSEN, REGARDED INVESTOR COUNSEL, Encourages Fortrea Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FTRE
-
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Fortrea Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FTRE
-
ROSEN, A LONGSTANDING FIRM, Encourages Fortrea Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FTRE
-
ROSEN, A LEADING LAW FIRM, Encourages Fortrea Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FTRE
-
Fortrea (FTRE) and Emery Pharma Announce Strategic Collaboration to Deliver FDA Compliant Drug-Drug-Interaction Studies Using Rifampin
-
Fortrea & Emery Pharma Announce Strategic Collaboration to Deliver FDA Compliant Drug-Drug-Interaction Studies Using Rifampin
-
Fortrea & Emery Pharma Announce Strategic Collaboration to Deliver FDA Compliant Drug-Drug-Interaction Studies Using Rifampin
-
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Fortrea Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FTRE
-
ROSEN, A LEADING LAW FIRM, Encourages Fortrea Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FTRE
-
ROSEN, A TOP RANKED LAW FIRM, Encourages Fortrea Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FTRE
-
Fortrea (FTRE) Adopts Limited-Duration Stockholder Rights Plan
-
Fortrea Adopts Limited-Duration Stockholder Rights Plan
-
Fortrea (FTRE) Names Anshul Thakral Chief Executive Officer
-
Fortrea Names Anshul Thakral Chief Executive Officer
-
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Fortrea Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FTRE
-
Fortrea to Present at the Jefferies Global Healthcare Conference
-
Fortrea (FTRE) Announces CEO Resignation
-
Fortrea Reports First Quarter 2025 Results
-
Fortrea Announces CEO Stepping Down
-
Fortrea Announces CEO Stepping Down
-
Fortrea Named a Leader in Everest Group’s Pharmacovigilance Operations PEAK Matrix® Assessment 2025
-
Fortrea Announces Date for First Quarter 2025 Financial Results and Conference Call
